Results 191 to 200 of about 45,189 (317)

Reviewing Advances in Rheumatoid Arthritis Treatment: From Disease-modifying Antirheumatic Drugs to Innovative Drug Delivery Systems [PDF]

Mohammad Reza Ghazanfari, Saeed Sepehrnia   +1 more
openalex   +1 more source

Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials [PDF]

, 2014
Gwan Gyu Song, Sang‐Cheol Bae, Young Ho Lee   +2 more
openalex   +1 more source

Effect of a smart temperature logger on correctly storing biological disease-modifying antirheumatic drugs at home: a pre-post study. [PDF]

Eur J Hosp Pharm
Haegens LL, Huiskes VJB, Bekker CL, van den Bemt BJF.   +3 more
europepmc   +1 more source

RESOLUTION OF THE PANEL OF EXPERTS ON «THE PHARMACEUTICAL PROVISION OF PSORIATIC ARTHRITIS PATIENTS WITH THE TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG APREMILAST AS TABLETS»

, 2018

openalex   +1 more source

Conventional and Biological Disease-Modifying Antirheumatic Drugs in Chro-nic Kidney Disease and Hemodialysis [PDF]

J. C. Santacruz Devia, Marta Juliana Mantilla, Sandra Pulido, Diana Cristina Varela, Carlos Alberto Agudelo, John Londoño   +5 more
openalex   +1 more source

Tofacitinib‐Induced Weight Gain in Context: comment on the article by Wollenhaupt et al.

ACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Andriko Palmowski, Frank Buttgereit, David Simon, Arnd Kleyer, Norman Michael Drzeniek   +4 more
wiley   +1 more source

Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. [PDF]

Rheumatol Int
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Proulx L, Tucker DR, De Vera MA.   +7 more
europepmc   +1 more source

Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation

, 2021
Abdurrahman Tufan, Marco Matucci‐Cerinic   +1 more
openalex   +2 more sources

Machine learning for predicting treatment response to biologic and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a scoping review. [PDF]

BMC Rheumatol
Eriakha EB, Han Y, Li M, Li J, Huang Y.
europepmc   +1 more source

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis [PDF]

, 2005
Baeten, Dominique, BOOTS, AM, CANETE, JD, De Keyser, Filip, De Rycke, Leen, FOELL, D, Kruithof, Elli, ROTH, J, VANDOOREN, BERNARD, Veys, Eric   +9 more
core